Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Porosome Therapeutics Announces New Porosome-Targeted Medicines Developed Using AI
-
Giant Containers Retained to Design, Deliver New Modular Structures for World-Leading EV Company
-
Stardust Power Joins Cornerstone Consortium to Support U.S. Critical Minerals and Industrial Base Resilience
-
Rekor Systems Announces Strategic On-Shoring of Overseas Engineering Operations to Advance Cost Discipline and Operational Efficiency
-
Paratek Pharmaceuticals Announces Positive Results for NUZYRA® Therapeutic Efficacy Studies in Inhalation Anthrax Triggering Additional Procurement under BARDA Project BioShield Contract
-
Applied Materials Awards Suppliers for Outstanding Performance
-
Alveus Therapeutics Announces Second and Final Closing of Oversubscribed Series A, Bringing Total Financing to $197 Million to Advance Next‑Generation Therapies for Obesity and Metabolic Diseases
-
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution
-
Mainz Biomed to Present at the Pancreatic Cancer Session at Digestive Disease Week, Demonstrating Effectiveness of mRNA Biomarkers in Blood Samples
-
ADW Capital Management Sends Letter to Compass Diversified’s Board Calling for an Immediate Strategic Review Process and Orderly Liquidation of the Company
-
Allied Announces Renewal Of Normal Course Issuer Bid
-
PTLE Announces 1-for-80 Share Consolidation
-
Rail Vision: Quantum Transportation Advancing Toward Quantum Hardware Integration
-
GDS Announces Adjournments of Extraordinary General Meeting and Additional Shareholders Meetings to be Reconvened on March 10, 2026
-
New real‑world data reinforce earlier use of Pluvicto™ before chemotherapy in metastatic castration-resistant prostate cancer
-
Gilat Receives $39 Million in Orders for Sidewinder ESA Terminals
-
Learning Tree International Awarded Multi-Year Sole-Award NATO NCIA Commercial Training Services Contract – IFB-CO-423236
-
Xometry Announces CEO Succession Plan
-
Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference
-
Xometry Reports Record Fourth Quarter and Strong Full Year 2025 Results
-
First Watch Restaurant Group, Inc. Announces Retirement of Chief Financial Officer Mel Hope and Transition Plan
-
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
-
New WJ V Nonverbal Cognitive Assessment from Riverside Insights Closes Critical Gap in Student Evaluation
-
New Survey Data Reveals What Canadian Mortgage Brokers Want Most from Private Lenders… and Most Aren’t Getting It
-
Aya Gold & Silver Identifies New Parallel Structure at Boumadine and Reports High-Grade Exploration Results
-
Dianthus Therapeutics to Participate in The TD Cowen 46th Annual Health Care Conference
-
Aptose Biosciences Announces Amendment to Arrangement Agreement and Details of Postponed Special Meeting of Shareholders
-
Kymera Therapeutics to Participate in Upcoming March Investor Conferences
-
Monte Rosa Therapeutics Presents Updated Clinical Data from Phase 1/2 Study of MRT-2359 in Combination with Enzalutamide in Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer Patients
-
Canada’s Rental Market Stabilizes in 2026 — But Supply Risks Are Building
-
The Canadian Queer Chamber of Commerce Launches The FAM Program to Support 2SLGBTQI+ businesses and Entrepreneurs Nationwide
-
Enviri Corporation Reports Fourth Quarter and Full Year 2025 Results
-
Presenting on Emerging Growth Conference 90 Day 1 on February 25; Register to live stream
-
New Publication Demonstrates Variant-Agnostic Correlate of Protection from COVID-19 for Invivyd Monoclonal Antibody, Useful for Understanding of and Confidence in COVID-19 Antibodies
-
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
-
Beam Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria (PKU)
-
Q2 Metals Discovers High Grade Zone with 170.2 Metre Intercept of 1.99% Li₂O, Including 40.1 m of 2.89% Li₂O at the Cisco Lithium Project
-
First Watch Restaurant Group, Inc. Reports 2025 Financial Results and Provides Outlook for 2026
-
Lahontan Drills High Grade Oxide Gold from the Surface at West Santa Fe: 37m Grading 3.11 g/t Au Eq Including 11m Grading 5.75 g/t Au Eq
-
EyePoint Announces Participation at Upcoming Investor Conferences
-
Larimar Therapeutics Announces FDA Breakthrough Therapy Designation for Nomlabofusp in FA and Reiterates Planned BLA Submission in June 2026
-
Ocular Therapeutix™ to Participate in March Investor Conferences
-
Ongwe Minerals Secures Additional Licenses, Significantly Increases Its Omatjete Project Area and Identifies Prospective Parallel Fault Zone
-
Garrett Motion Announces Participation at the Bank of America Global Automotive Summit
-
Atea Pharmaceuticals Presents Preclinical Results Supporting First-in-Class Potential of AT-587 for Treatment of Hepatitis E Virus at CROI 2026
-
Mobilicom to Participate at Enforce Tac 2026, Germany’s Prominent Trade Fair for Security and Defense
-
AMD and Meta Announce Expanded Strategic Partnership to Deploy 6 Gigawatts of AMD GPUs
-
Cipher Digital Provides Fourth Quarter and Full Year 2025 Business Update
-
Transcenta Therapeutics to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference
-
Cullinan Therapeutics to Participate in Upcoming Investor Conferences
